427 related articles for article (PubMed ID: 31616427)
41. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mandler M; Valera E; Rockenstein E; Mante M; Weninger H; Patrick C; Adame A; Schmidhuber S; Santic R; Schneeberger A; Schmidt W; Mattner F; Masliah E
Mol Neurodegener; 2015 Mar; 10():10. PubMed ID: 25886309
[TBL] [Abstract][Full Text] [Related]
42. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.
Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M
Nat Commun; 2019 Dec; 10(1):5535. PubMed ID: 31797870
[TBL] [Abstract][Full Text] [Related]
43. Humoral response against small heat shock proteins in Parkinson's disease.
Papuć E; Kurys-Denis E; Krupski W; Rejdak K
PLoS One; 2015; 10(1):e0115480. PubMed ID: 25629316
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.
Cong S; Xiang C; Wang H; Cong S
J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061
[TBL] [Abstract][Full Text] [Related]
45. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
46. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.
Li Y; Wang T; Meng L; Jin L; Liu C; Liang Y; Ren L; Liu Y; Liu Y; Liu S; Li T; Liang Y; Chen X; Zhang Z
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12860. PubMed ID: 36331758
[TBL] [Abstract][Full Text] [Related]
47. Hemoglobin-binding α-synuclein levels in erythrocytes are elevated in patients with multiple system atrophy.
Zhang X; Wang S; Li X; Li X; Ran W; Liu C; Tian W; Yu X; Wu C; Li P; Li N; Wei Y; Wang Y; Yu S; Chen Z
Neurosci Lett; 2022 Oct; 789():136868. PubMed ID: 36087813
[TBL] [Abstract][Full Text] [Related]
48. Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
Rydbirk R; Elfving B; Andersen MD; Langbøl MA; Folke J; Winge K; Pakkenberg B; Brudek T; Aznar S
Neurobiol Dis; 2017 Oct; 106():269-278. PubMed ID: 28732710
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
50. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
51. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
[TBL] [Abstract][Full Text] [Related]
52. A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic α-Synuclein in Parkinson's Disease.
Wang L; Wang G; Duan Y; Wang F; Lin S; Zhang F; Li H; Li A; Li H
Neurodegener Dis; 2019; 19(5-6):204-210. PubMed ID: 32485710
[TBL] [Abstract][Full Text] [Related]
53. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
Shults CW; Barrett JM; Fontaine D
Neurosci Lett; 2006 Sep; 405(3):223-5. PubMed ID: 16901642
[TBL] [Abstract][Full Text] [Related]
54. Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.
Valera E; Monzio Compagnoni G; Masliah E
Neuropathol Appl Neurobiol; 2016 Feb; 42(1):95-106. PubMed ID: 26924723
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Vogt IR; Lees AJ; Evert BO; Klockgether T; Bonin M; Wüllner U
Exp Neurol; 2006 Jun; 199(2):465-78. PubMed ID: 16626704
[TBL] [Abstract][Full Text] [Related]
56. Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser
Dutta S; Hornung S; Taha HB; Biggs K; Siddique I; Chamoun LM; Shahpasand-Kroner H; Lantz C; Herrera-Vaquero M; Stefanova N; Loo JA; Bitan G
ACS Chem Neurosci; 2023 Apr; 14(7):1238-1248. PubMed ID: 36920792
[TBL] [Abstract][Full Text] [Related]
57. Analysis of colonic alpha-synuclein pathology in multiple system atrophy.
Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049
[TBL] [Abstract][Full Text] [Related]
58. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
59. The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy.
Abdul-Rahman T; Herrera-Calderón RE; Ahluwalia A; Wireko AA; Ferreira T; Tan JK; Wolfson M; Ghosh S; Horbas V; Garg V; Perveen A; Papadakis M; Ashraf GM; Alexiou A
CNS Neurosci Ther; 2024 Apr; 30(4):e14678. PubMed ID: 38572788
[TBL] [Abstract][Full Text] [Related]
60. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
